Insulin resistance and cardiovascular disease

American Journal of Hypertension

Volumn 14, Issue 6 II, 2001, Pages

  Egan, Brent M ^a   Greene, Eddie L ^b   Goodfriend, Theodore L ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Angiotensin; Blood pressure; Fatty acids; Insulin resistance; Oxidative; Risk factor cluster

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; INSULIN; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR;

CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL PROLIFERATION; CONFERENCE PAPER; FATTY ACID METABOLISM; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; INSULIN RESISTANCE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; VASCULAR SMOOTH MUSCLE;

EID: 0034981891     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(01)02078-7     Document Type: Conference Paper

References (124)

1. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease
2. Hyperinsulinemia as an independent risk factor for ischemic heart disease
3. Epidemiology of insulin resistance and its relation to coronary artery disease
4. Insulin resistance and hyperinsulinemia in individuals with small, dense, low-density lipoprotein particles
5. Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy women
6. Obesity: Observations on one thousand cases
7. Obesity is an independent risk factor for cardiovascular disease: A 26 year follow-up of participants in the Framingham Heart Study
8. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults
9. Obesity, health services use, and health care costs among members of a health maintenance organization
10. The spread of the obesity epidemic in the United States, 1991-1998
11. Socioeconomic issues affecting the treatment of obesity in the new millennium
12. Insulin resistance and hypersecretion in obesity
13. Body mass index and percent body fat: A meta-analysis among different ethnic groups
14. Plasma free and non-sex-hormone-binding-globulin-testosterone are decreased in obese men in proportion to their degree of obesity
15. Body mass index and blood pressure in Korean men and women: The Korean National Blood Pressure Survey
16. Weight as a risk factor for clinical diabetes in women
17. Body weight and mortality among women
18. Angiotensinogen levels and obesity in four black populations
19. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone concentrations
20. Obesity is associated with tissue-specific activation of renal angiotensin converting enzyme in vivo: Evidence for a regulatory role of endothelin
21. Renin and aldosterone are higher and the hyperinsulinemic effects of salt restriction greater in subjects with risk factor clustering
22. The relation of adiposity to blood pressure and development of hypertension
23. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients
24. Tissue-specific nutritional regulation of angiotensiogen in adipose tissue
25. The role of angiotensin II and its receptors in regulation of adipose tissue metabolism and cellularity
26. Regulation by fatty acids of angiotensinogen gene expression in preadipose cells
27. Angiotensinogen gene expression in adipose tissue: Analysis of obese models and hormonal and nutritional control
28. Genetic control of BP and the angiotensinogen locus
29. Angiotensin-converting enzyme gene mutations, blood pressure, and cardiovascular homeostasis
30. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II
31. Insulin resistant lipolysis in abdominally-obese hypertensives: Role of the renin-angiotensin system
32. Fatty acids are potential endogenous regulators of aldosterone secretion
33. Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans
34. Blood pressure and renal function during chronic changes in sodium intake: Role of angiotensin
35. Role of aldosterone in the remnant kidney
36. Aldosterone is a major factor in the progression of renal disease
37. Mechanism of protective effects of ACE inhibition in coronary artery disease
38. Inhibition of tissue repair by spironolactone: Role of mineralocorticoids in fibrous tissue formation
39. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a "no-salt" culture
40. Oleic acid and angiotensin induce a synergistic mitogenic response
41. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth
42. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan
43. Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects
44. Serum leptin and weight gain over 8 years in African American and Caucasian young adults
45. Cardiovascular consequences of obesity: Role of leptin
46. Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men
47. Kidney Int
48. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance
49. The expression of tumor necrosis factor in human adipose tissue: Regulation by obesity, weight loss, and relationship to lipoprotein lipase
50. Tumor necrosis factor α is a key component in obesity-linked elevation of plasminogen activator inhibitor 1
51. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
52. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats
53. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure
54. Influence of body fat distribution on free fatty acid metabolism in obesity
55. Reduced hepatic insulin clearance in rats with dietary-induced obesity
56. Effect of fatty acids on glucose production and utilization in man
57. Impaired fatty acid metabolism in familial combined hyperlipidemia: A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance
58. The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
59. Fatty acid-induced β cell apoptosis: A link between obesity and diabetes
60. Unsaturated fatty acids increase plasminogen activator inhibitor-1 in endothelial cells
61. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo
62. Reversibility of the effects on local circulation of high lipid concentrations in blood
63. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
64. Mechanisms in the pressor effects of hepatic portal venous fatty acid infusion
65. Adiposity, fat distribution and cardiovascular risk
66. Pathogenesis of weight related changes of blood pressure in dogs
67. Obesity-induced hypertension: Renal function and systemic hemodynamics
68. Blood pressure and hormone changes associated with weight reduction in the obese
69. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus
70. Obesity hypertension is more closely related to impairment of insulin's fatty acid than glucose lowering action
71. Postprandial free fatty acid kinetics are abnormal in upper body obesity
72. Measurement of plasma glucose, free fatty acids, lactate, and insulin for 24 hours in patients with NIDDM
73. Familial dylipidemic hypertension: Evidence from 58 Utah families for a syndrome present in ∼ 12% of patients with essential hypertension
74. High free fatty acid concentration: An independent risk factor for hypertension in the Paris Prospective Study
75. Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells
76. 2α concentrations in normal volunteers
77. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats
78. A clinical trial of the effects of dietary patterns on blood pressure
79. Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: Results from Phase 1 of the Trials of Hypertension Prevention
80. Direct regulation of ion channels by fatty acids
81. Fatty acids enhance endothelium-dependent dilation in hand veins by a cyclooxygenase dependent mechanism
82. Infusion of intralipid and heparin leads to generation of 6-keto-prostaglandin F1α in dorsal hand veins
83. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages
84. Regulation of platelet protein kinase C by oleic acid
85. Selective regulation of protein kinase C isozymes by oleic acid in human platelets
86. Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation
87. Endothelium and growth factors in vascular remodeling in hypertension
88. Impairment of relaxation to acetylcholine and nitric oxide by a phorbol ester in rat isolated aorta
89. Protein kinase C activators suppress stimulation of capillary endothelial cell growth by angiogenic endothelial mitogens
90. Enhanced stimulation of diacylglycerol and lipid synthesis by insulin in denervated muscle: Altered PKC activity and possible link to insulin resistance
91. Dietary energy restriction-induced modulation of protein kinase Cζ in the hamster pancreas
92. Protein kinase Cζ is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus. An alteration not due to hyperglycemia
93. Purification and characterization of the ζ isoform of protein kinase C from bovine kidney
94. Protein kinase C-ζ mediates angiotensin II activation of ERK-1 and-2 in vascular smooth muscle cells
95. Protein kinase C ζ is critical for mitogenic signal transduction
96. Irreversible inactivation of protein kinase C by glutathione
97. Activation of the human neutrophil nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase by protein kinase C
98. Redistribution of protein kinase C activity in human monocytes: Correlation with activation of the respiratory burst
99. 2+-dependent protein kinase
100. Hydrogen peroxide and fetal bovine serum-induced DNA synthesis in vascular smooth muscle cells: Positive and negative regulation by protein kinase C isoforms
101. 5HT2A receptors stimulate mitogen-activated protein kinase via reactive oxygen species in rat mesangial cells
102. - in vascular smooth muscle cells
103. Reactive oxygen intermediates are involved in the intracellular transduction of angiotensin II signal in C2C12 cells
104. Reactive oxygen species stimulate insulin-like growth factor I synthesis in vascular smooth muscle cells
105. Reactive oxygen species-induced impairment of endothelium-dependent relaxation in rat aortic rings: Protection by L-arginine
106. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of matrix metalloproteinases
107. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
108. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability
109. Reactive oxygen intermediates mediate angiotensin II-induced c-jun/c-fos heterodimer DNA binding activity and proliferative hypertrophic responses in myogenic cells
110. phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells
111. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation
112. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II
113. Signaling events mediating the additive effects of oleic acid and angiotensin II on vascular smooth muscle cell migration
114. Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes
115. Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients
116. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes
117. Effect of modest vitamin E supplementation on blood glycated hemoglobin and triglyceride levels and red cell indices in type I diabetic patients
118. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study
119. Dietary flavonoids, antioxidant vitamins and incidence of stroke
120. Tea flavonoids may protect against atherosclerosis, the Rotterdam Study
121. Fruit and vegetable intake in relation to risk of ischemic stroke
122. Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States
123. Oxidants, oxidative stress, and the biology of aging